At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ABVX Abivax S.A.
Market Closed 09-18 16:00:00 EDT
105.04
-1.95
-1.82%
盘后104.50
-0.54-0.51%
19:48 EDT
High107.19Low103.89Vol876.03K
Open107.00D1 Closing106.99Amplitude3.08%
Mkt Cap9.14BTradable Cap8.03BTotal Shares87.05M
T/O91.94MT/O Rate1.15%Tradable Shares76.46M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish
Earnings Agent  ·  09-14
Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish
Will Abivax Stock (ABVX) Rise or Fall After Q2 Earnings?
TIPRANKS  ·  09-19 01:18
Will Abivax Stock (ABVX) Rise or Fall After Q2 Earnings?
Abivax SA Expected to Post a Loss of €1.06 a Share - Earnings Preview
Reuters  ·  09-18 22:02
Abivax SA Expected to Post a Loss of €1.06 a Share - Earnings Preview
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  09-18 18:00
Calendar of U.S. Earnings Expected in the Week Ahead
Movement Alert｜Abivax S.A. Rises 5.06% in Regular Trading, Institutional Bullish Views and Pipeline Progress Drive Rebound
Market Focus  ·  09-17 23:40
Movement Alert｜Abivax S.A. Rises 5.06% in Regular Trading, Institutional Bullish Views and Pipeline Progress Drive Rebound
Unusually active option classes on open September 16th
TIPRANKS  ·  09-16
Unusually active option classes on open September 16th
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  09-16
Calendar of U.S. Earnings Expected in the Week Ahead
Movement Alert｜Abivax S.A. Falls 5.33% in Regular Trading, Upcoming Earnings Forecast Points to Over 40% Revenue Decline
Market Focus  ·  09-15
Movement Alert｜Abivax S.A. Falls 5.33% in Regular Trading, Upcoming Earnings Forecast Points to Over 40% Revenue Decline
Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga Earnings  ·  09-14
Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals
Reuters  ·  09-10
U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals
Abivax Sa: Shares up 2.8% After Gs Initiates at 'Buy'
THOMSON REUTERS  ·  09-10
Abivax Sa: Shares up 2.8% After Gs Initiates at 'Buy'
Abivax Sa : Goldman Sachs Initiates Coverage with Buy Rating
THOMSON REUTERS  ·  09-10
Abivax Sa : Goldman Sachs Initiates Coverage with Buy Rating
Abivax initiated with a Buy at Goldman Sachs
TIPRANKS  ·  09-10
Abivax initiated with a Buy at Goldman Sachs
Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod
THOMSON REUTERS  ·  07-31
Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod
Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026
THOMSON REUTERS  ·  07-31
Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026
Movement Alert｜Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180
Market Focus  ·  07-30
Movement Alert｜Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180
Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says
MT Newswires Live  ·  07-24
Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says
Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating
MT Newswires Live  ·  07-24
Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating
Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up
Reuters  ·  07-24
Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up
Abivax re-engages Centerview amid renewed takeover interest, La Lettre says
TIPRANKS  ·  07-18
Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

Introduction

Company Name.
Abivax S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Issue price:
--